D1 Striatal Medium Spiny Neurons In Huntington'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Pathway / Mechanism Diagram
...
D1 Striatal Medium Spiny Neurons in Huntington's Disease
D1 Striatal Medium Spiny Neurons In Huntington'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Pathway / Mechanism Diagram
Mermaid diagram (expand to render)
Overview
D1-expressing medium spiny neurons (D1-MSNs) are selectively vulnerable in Huntington's disease, contributing to the characteristic motor and cognitive symptoms. Unlike Parkinson's disease where D2-MSNs are primarily affected, HD shows early and severe loss of the direct pathway neurons. [@reiner2013]
mHTT → ↓ PGC-1α → Mitochondrial dysfunction → Energy failure
Synaptic Dysfunction
Loss of cortical inputs
Reduced dopamine modulation
NMDA receptor excitotoxicity
GABAergic signaling changes
Motor Manifestations
Direct Pathway Dysfunction
Loss of D1-MSNs → Reduced facilitation
Reduced movement initiation
Bradykinesia contribution
Parkinsonism in some patients
Chorea Relationship
D1-D2 imbalance hypothesis
D1-MSN loss → Relative D2 overactivity
Dopamine replacement worsens chorea
Cognitive Implications
Executive Dysfunction
Striosome degeneration → Cognitive inflexibility
Loss of habit learning
Working memory deficits
Set-shifting impairment
Psychiatric Symptoms
Depression association
Irritability and aggression
Apathy progression
Therapeutic Approaches
Current Treatments
Tetrabenazine: VMAT2 inhibitor
Antipsychotics: D2 blockade
Amantadine: NMDA modulation
Emerging Therapies
Gene silencing: ASOs targeting HTT
Neurotrophic factors: BDNF delivery
Cell replacement: Stem cell approaches
Background
The study of D1 Striatal Medium Spiny Neurons In Huntington'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[D1 Striatal Medium Spiny Neurons in Huntington's Disease](http://scidex.ai/artifact/wiki-cell-types-d1-striatal-medium-spiny-neurons-in-huntingtons-disease)